Equity Overview
Price & Market Data
Price: $0.0285
Daily Change: -$0.007 / 24.56%
Daily Range: $0.0285 - $0.033
Market Cap: $1,353,662
Daily Volume: 23,024
Performance Metrics
1 Week: -25.70%
1 Month: -33.72%
3 Months: -41.96%
6 Months: -38.44%
1 Year: -57.37%
YTD: -38.16%
Details
Algernon Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Pharmaceuticals Inc. and changed its name to Algernon Health Inc. in October 2025. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.